JPRN-UMIN000033007
Recruiting
未知
Study of efficacy and safety of dose reduction in the oral cavity by target volume definition using PET/CT for intensity-modulated radiation therapy of head and neck cancers - Study of efficacy and safety of dose reduction in the oral cavity by target volume definition using PET/CT for intensity-modulated radiation therapy of head and neck cancers
Juntendo University,Graduate School of Medicine,Department of Radiation Oncology0 sites10 target enrollmentJune 16, 2018
ConditionsHead-and-neck cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Head-and-neck cancer
- Sponsor
- Juntendo University,Graduate School of Medicine,Department of Radiation Oncology
- Enrollment
- 10
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Patients have psychiatric disorders that may comprise the patient's ability to receive radiotherapy 2\.Patients who is considered ineligible for enrolling the study by a principal investigator or sub\-investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of the safety and efficacy of low dose transgenic rice containing peptides from Japanese cedar pollen allergens.JPRN-UMIN000016078The Jikei University, School of Medicine21
Recruiting
Phase 4
A clinical trial to study the efficacy and safety of low dose versus standard dose emicizumab prophylaxis in haemophilia A patients.Health Condition 1: D66- Hereditary factor VIII deficiencyCTRI/2024/01/061593Department of Health Research, India
Completed
Not Applicable
Randomised controlled study of dose reduction and withdrawal strategies of adalimumab and etanercept in rheumatoid arthritis: saving costs at what expense?chronic arthritisrheumatoid arthritis10023213NL-OMON38325Sint Maartenskliniek180
Not yet recruiting
Not Applicable
Assessment of effectiveness and safety of minimal doses of propofol for sedation for MRI in childreHealth Condition 1: G80- Cerebral palsyHealth Condition 2: K00-K95- Diseases of the digestive systemHealth Condition 3: M00-M99- Diseases of the musculoskeletal system and connective tissueHealth Condition 4: G00-G99- Diseases of the nervous systemHealth Condition 5: G40- Epilepsy and recurrent seizuresCTRI/2019/11/022044OKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND LOKMANYA MUNICIPAL GENERAL HOSPITA
Active, not recruiting
Not Applicable
ow doses of Rituximab in Graves orbitopathyActive moderate to severe Graves OrbitopathyMedDRA version: 14.1Level: PTClassification code 10060742Term: Endocrine ophthalmopathySystem Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Hormonal diseases [C19]EUCTR2012-001980-53-ITFONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO10